Work

419P A randomized, controlled, multicenter study to evaluate the therapeutic equivalence between FKS518 proposed biosimilar to denosumab and the reference denosumab in postmenopausal women with osteoporosis (LUMIADE-3 study)

Year: 2025
Type: article
Source: ESMO Open
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W4410455665
FWCI: 1.015
Cites:
Cited by: 1
Related to: 10